ºÚÁϲ»´òìÈ

Although the current guidelines for extractables and leachables (E&L) studies are general and the exact criteria for every situation or form of manufacturing, packaging, and delivery systems are not outlined, E&L risk assessment is critical to the pharmaceutical drug development process.

This white paper reviews the challenges E&L studies present to manufacturers, and demonstrates how a trusted laboratory partner can help overcome common problems faced during production and packaging.

To learn more about E&L challenges and solutions, download the free white paper below.

E&L Challenges During Pharmaceutical Drug Manufacturing and Development includes information on

• E&L supply chain complexities
• E&L container closure requirements
• E&L challenges that affect cost and turnaround times
• Selecting an analytical partner